Healx Logo

Company

Investors

Invest in the future of drug discovery

We’re proud to be supported by some of the world’s leading investors who have a strong track record of working with successful, high-growth companies.

We’ve raised over $70 million to date and are grateful for the continued support of our partners – from seed round to Series B and beyond.

We are always keen to hear from companies who share our vision to use AI to accelerate the discovery and development of rare disease treatments at scale. Please get in touch to explore ways of working together.

Contact us
Vector

Our technology

Our AI leverages its unique combination of algorithms to predict and de-risk novel connections in biomedical data, and move the most promising ones towards the clinic.

Find us on social media